Chemotherapy vs Immunotherapy for Head & Neck Cancer: What Patients Should Know

Описание: Chemotherapy vs Immunotherapy for Head & Neck Cancer: What Patients Should Know

In this video, Professor Chris Nutting, consultant oncologist in London, explains the key differences between chemotherapy and immunotherapy in the treatment of head and neck cancer.

You’ll learn:
💉 How chemotherapy works – usually delivered intravenously, with common side effects like fatigue, appetite loss, altered taste, mouth soreness, and occasional nausea. Rare side effects may include hearing changes or nerve symptoms.

🧬 How immunotherapy works – boosting the immune system to recognise and fight cancer. Generally better tolerated, with tiredness being the most common effect, but with rare risks of immune-related inflammation (lungs, bowel, or other organs).

⚖️ Why patient selection matters – recent clinical trials show that not every patient will benefit equally. Some respond better to chemotherapy, while others may achieve more with immunotherapy.

✅ Overall conclusion – immunotherapy is usually easier for patients to tolerate, but treatment choice should always be tailored to the individual case.

Subscribe to my channel for trusted information on thyroid, head and neck cancer care, and expert-led guidance on treatment options.

Don’t forget to like, share, and comment to stay up to date with the latest in cancer treatment and patient support.

Bio:
Professor Christopher Nutting is a leading Consultant Clinical Oncologist based in London, specialising in the treatment of head and neck, thyroid, and lung cancers. He practices at The Royal Marsden Hospital and The Institute of Cancer Research, where he also serves as Professor of Clinical Oncology. Renowned for pioneering advanced radiotherapy techniques, including Intensity-Modulated Radiotherapy (IMRT), Professor Nutting has significantly contributed to improving patient outcomes and quality of life. His extensive research portfolio includes leadership roles in major clinical trials such as PARSPORT, COSTAR, ARTDECO, and DARS. With over 300 peer-reviewed publications and numerous national and international accolades, he continues to influence cancer treatment protocols both in the UK and globally.   

Tags:
Professor Chris Nutting, Clinical Oncologist, Thyroid Cancer, Head and Neck Cancer, Radioiodine Treatment, Cancer Care UK, Oncology Expert, Personalised Cancer Treatment, London Oncologist, Cancer Treatment Explained, Radiotherapy Specialist, Cancer Patient Support, Remote Cancer Consultation, Royal Marsden Hospital, Cancer Diagnosis and Care, IMRT Radiotherapy, Consultant Oncologist UK, Cancer Education, NHS and Private Oncology, Advanced Cancer Treatment

👉 Follow me on Instagram: / christopher.nutting

👉 Follow me on Facebook: / DrChrisNutting

🔗 Let’s connect on LinkedIn: / drchrisnutting

🌐︎ Visit www.chrisnutting-oncology.co.uk